Skip to main content

Table 3 Gene expression in chronic kidney disease bone marrow cells not changed after in vitro treatment with pravastatin

From: Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease

  DMEM ( n = 10) Pravastatin ( n = 10) P value
TNFα 1.000 ± 1.290 0.868 ± 0.969 0.7504
eNOS 1.000 ± 4.609 2.161 ± 2.874 0.5422
PKB 1.000 ± 0.889 0.905 ± 0.5512 0.6906
MCP-1 1.000 ± 1.254 1.191 ± 0.6933 0.6101
VEGF 1.000 ± 0.566 0.687 ± 0.464 0.0807
  1. Data presented as mean ± standard deviation, expressed as fold change. DMEM, Dulbecco’s modified Eagle medium; eNOS, endothelial nitric oxide synthase; MCP-1, monocyte chemotactic protein 1; PKB, protein kinase B; TNFα, tumor necrosis factor alpha; VEGF, vascular endothelial growth factor.